Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
| Image |  |
|---|---|
| Description | scientific article published on 16 April 2018 |
| Author/s |
author: Zeev Estrov Elias J Jabbour Naval Daver Jorge Eduardo Cortes Rita Assi Gautam Borthakur Hagop Kantarjian Naveen Pemmaraju Tapan M Kadia |
| Publication date | April 16, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |